Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kaye

Showing results (671-680 of 853) with videos related to

Pageof 86
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeksS Senan, R Rampling, M A Graham, et al.
Oral Surgery, Oral Medicine, and Oral Pathology|November 1, 1984
The effect of cytotoxic therapy on saliva and oral floraB E Main, K C Calman, M M Ferguson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Implications of BRCA1 and BRCA2 mutations for the efficacy of paclitaxel monotherapy in advanced ovarian cancerDavid S P Tan, Timothy A Yap, Margaret Hutka, et al.
Hematological Oncology|January 1, 1990
The myelotoxicity of carboplatin is influenced by the time of its administrationD J Kerr, C Lewis, B O'Neil, et al.
The Biochemical Journal|December 12, 2022
Impact of fluoroquinolones and aminoglycosides on P. aeruginosa virulence factor production and cytotoxicityDaniel M Foulkes, Keri McLean, Marta Sloniecka, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analoguesD Cunningham, C J Bradley, G J Forrest, et al.
British Journal of Cancer|April 1, 1992
Phase II trials of fosquidone, (GR63178A), in colorectal, renal and non-small cell lung cancer. CRC Phase II Clinical Trials CommitteeS B Kaye, M Brampton, P Harper, et al.
American Journal of Ophthalmology|March 15, 2022
Factors Affecting the Success Rate of Preloaded Descemet Membrane Endothelial Keratoplasty With Endothelium-Inward Technique: A Multicenter Clinical StudyMohit Parekh, Emilio Pedrotti, Pietro Viola, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1984
Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized studyJ A Elliott, S Ahmedzai, D Hole, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
A phase II, randomized, placebo-controlled study of vismodegib as maintenance therapy in patients with ovarian cancer in second or third complete remissionStanley B Kaye, Louis Fehrenbacher, Robert Holloway, et al.
Pageof 86

Showing results (671-680 of 853) with videos related to

Sort By:
Pageof 86
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeksS Senan, R Rampling, M A Graham, et al.
Oral Surgery, Oral Medicine, and Oral Pathology|November 1, 1984
The effect of cytotoxic therapy on saliva and oral floraB E Main, K C Calman, M M Ferguson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Implications of BRCA1 and BRCA2 mutations for the efficacy of paclitaxel monotherapy in advanced ovarian cancerDavid S P Tan, Timothy A Yap, Margaret Hutka, et al.
Hematological Oncology|January 1, 1990
The myelotoxicity of carboplatin is influenced by the time of its administrationD J Kerr, C Lewis, B O'Neil, et al.
The Biochemical Journal|December 12, 2022
Impact of fluoroquinolones and aminoglycosides on P. aeruginosa virulence factor production and cytotoxicityDaniel M Foulkes, Keri McLean, Marta Sloniecka, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analoguesD Cunningham, C J Bradley, G J Forrest, et al.
British Journal of Cancer|April 1, 1992
Phase II trials of fosquidone, (GR63178A), in colorectal, renal and non-small cell lung cancer. CRC Phase II Clinical Trials CommitteeS B Kaye, M Brampton, P Harper, et al.
American Journal of Ophthalmology|March 15, 2022
Factors Affecting the Success Rate of Preloaded Descemet Membrane Endothelial Keratoplasty With Endothelium-Inward Technique: A Multicenter Clinical StudyMohit Parekh, Emilio Pedrotti, Pietro Viola, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1984
Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized studyJ A Elliott, S Ahmedzai, D Hole, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
A phase II, randomized, placebo-controlled study of vismodegib as maintenance therapy in patients with ovarian cancer in second or third complete remissionStanley B Kaye, Louis Fehrenbacher, Robert Holloway, et al.
Pageof 86